Latest filing published 15 Sept 2026 for Tevogen Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Susan M. Podlogar (senior executive) discloses dealings in 3 companies, chiefly Metlife Inc, Tevogen Inc. and LivaNova PLC. Over a trading history stretching from 4 March 2019 to 11 September 2026, the count stands at 19 filings.
Every open-market trade on record is a sale: 1 sale worth €203k. The rest of the record consists of 13 share grants and 5 option exercises.
The latest filing, published on 15 September 2026, reports a share grant in Tevogen Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations